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Introduction
Renal cell carcinoma (RCC) in autosomal dominant
polycystic kidney disease (ADPKD) is very rare. Only
a total of about 50 cases of ADPKD-associated RCCs
have been reported since 1934,1,2 and only 11 cases
of bilateral RCC in ADPKD have been reported since
1954.2 Herein, we present a case of bilateral RCC with
different cell variants in ADPKD.
Case Report
This 58-year-old man had ADPKD with end-stage renal
disease under regular hemodialysis since September
1988. Bilateral multiple renal tumors were noted inci-
dentally on ultrasonography in April 2004 during
annual follow-up. Computed tomography (CT) of the
abdomen was performed, and autosomal dominant
polycystic disease with bilateral renal malignancy was
suspected (Figure 1).
Under the impression of ADPKD with bilateral
renal tumors, the patient received laparoscopic bilat-
eral radical nephrectomy in May 2004. Two tumor
masses, 8 × 6 × 6 cm and 2 × 1 × 1 cm, were noted in
the right kidney, and the pathologic reports showed
papillary RCC, eosinophilic variant, pT2 and pT1
(Figure 2A). Two other tumor masses, 5 × 4 × 4 cm
and 4 × 4 × 3.5 cm, were noted in the left kidney, and
the pathologic reports showed conventional RCC, pT1
with cystic necrosis in 1 mass and pT1 without necrosis
in the other (Figure 2B). The non-neoplastic parts of
both kidneys were confirmed as adult polycystic kidney
disease by the pathologist.
Postoperative recovery was smooth, and the patient
was discharged and then regularly followed-up at the
outpatient department (OPD). There has been no evi-
dence of local recurrence or distant metastasis till now.
Discussion
Since 1934, there have only been about 50 cases of
RCC in ADPKD,1,2 and since 1954, only 11 cases of
bilateral RCC in ADPKD.2 The prevalence of the
ADPKD gene is 1:1,000 and the age-adjusted inci-
dence of RCC is 5–6/100,000/year in the general
population. The chance of both conditions occurring
in the same individual is not impossible but is rare.3
In this case, there were 2 types of cell variants in bilat-
eral polycystic kidneys with papillary RCC, eosinophilic
variant and conventional RCC. Though the current
data revealed that the incidence of ADPKD-associated
RCC is not higher than that of RCC in the general
population,4 some findings of ADPKD-associated
RCCs are different from those of RCC in the general
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population. For example, the age of presentation in
ADPKD-associated RCCs is younger than that in the
general population (45 years vs. 61 years), fever is 
a more common presenting symptom of RCC in
ADPKD (32%) than in the general population (7%),
and RCC in ADPKD is more often concurrently bilat-
eral (12% vs. 1–5%), multicentric (28% vs. 6%), and
sarcomatoid in type (33% vs. 1–5%) than in the general
population.4
The different types of kidney cancer have different
histologic characteristics and different clinical courses,
and they are caused by different genes.5 The gene for
the inherited form of clear RCC associated with the
von Hippel-Lindau (VHL) gene has been identified.
This gene was found to be a tumor suppressor gene.5
The gene of hereditary papillary renal carcinoma was
identified to be the proto-oncogene c-Met. It was
found to be located at chromosome 7q31.1-34 in a
27-cM interval between the 2 anonymous markers
D75496 and D751837.5 Understanding the genetic
basis of the renal tumor provides potentially better
methods of diagnosis and new forms of therapy.
Although the PKD1 and PKD2 genes are associated
with ADPKD,6 the associated chromosome or gene
changes between RCC and ADPKD are unknown.1
The preoperative diagnosis of RCC in the context
of ADPKD may be difficult, because the tumor may
be masked by the complex cystic background super-
imposed by bleeding, degenerated blood clot, pro-
teinaceous debris, and infection.4,7 Accordingly, the
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Figure 1. Abdominal computed tomography shows left lower pole renal mass (arrow): (A) pre-contrast, attenuation coefficient is
36.6 HU; (B) post-contrast enhancement, attenuation coefficient is 50.3 HU.
A B
Figure 2. Pathologic pictures of renal cell carcinoma (RCC) of the bilateral kidney: (A) papillary RCC of the right kidney (400×); (B) con-
ventional RCC of the left kidney (400×).
follow-up of ADPKD patients should be very careful.
Recently, Lang and Davis8 reported the diagnostic
strategy of RCC in ADPKD by CT. Neoplasms
between or in cysts have attenuation coefficients of
+30 to +40 Hounsfield Units (HU) in the pre-
enhancement phase. In the arterial corticomedullary
phase of CT, there is a sharp increase in the attenua-
tion coefficient to +70 to +150 HU. In the parenchy-
mal phase, the attenuation coefficient progressively
decreases to +45 to +65 HU. In RCC, however, the
attenuation coefficient further decreases to +35 to
+50 HU (washout phenomenon). In this case, the
pre-enhanced attenuation coefficient, 35.9 HU and
36.6 HU in right and left kidneys, respectively, and
the post-enhanced (parenchymal) attenuation coeffi-
cient, 47.6 HU and 50.3 HU in right and left kid-
neys, respectively, were compatible with the report of
Lang and Davis. Because it is difficult to find small
tumor masses in the cystic background, a high index of
suspicion is recommended when we follow ADPKD
patients.2
The treatment of choice in patients with ADPKD
and bilateral renal tumors is the traditional open trans-
abdominal bilateral nephrectomy, which carries signif-
icant morbidity.9 The bilateral hand-assisted radical
nephrectomy in a single setting for these patients was
proved to be a safe and effective alternative procedure
with less morbidity.10 The prognosis of patients with
ADPKD and RCC depends on the stage of the disease
and is not different from that of RCC patients in the
general population.
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